Binnopharm Group, a member of Sistema JSFC, launched production of molnupiravir for treatment of COVID-19 at a plant in the Moscow region. The drug will be produced in Russia on a full cycle. The capacity of the plant allows to produce up to 15 million packs of molnupiravir per year.